🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer

Recruitingn/aAges 18 Years - anyFemaleFatih GURLER
NCT07588425 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate cardiac side effects in women with early-stage breast cancer who receive systemic chemotherapy and/or anti-HER2 therapy as part of their standard cancer care. The main questions it aims to answer are: Can changes in Global Longitudinal Strain (GLS) on echocardiography detect early cardiac dysfunction before a drop in left ventricular ejection fraction (LVEF) becomes apparent? Are changes in circulating microRNA levels in the blood associated with early cardiac dysfunction during cancer treatment? Does cardiac dysfunction occur more frequently with anthracycline-containing chemotherapy compared to anthracycline-free regimens? Participants already receiving standard chemotherapy and/or anti-HER2 therapy as part of their routine cancer care will undergo echocardiography (LVEF and GLS), provide blood samples for microRNA analysis, and co

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Histologically confirmed diagnosis of breast cancer * Stage I, II, or III disease * Planned neoadjuvant or adjuvant chemotherapy and/or HER2-targeted systemic therapy * Baseline transthoracic echocardiographic left ventricular ejection fraction (LVEF) ≥ 50% * Age ≥ 18 years * Able and willing to provide written informed consent Exclusion Criteria: * Metastatic (Stage IV) breast cancer * Pre-existing heart failure or clinically significant cardiac disease * Prior exposure to chemotherapy or other cardiotoxic systemic therapy * Concurrent active malignancy other than breast cancer * Inability or unwillingness to comply with the planned follow-up and assessment schedule
💊

What it tests

  • Not listed
📍

Where

1 site
Gazi University Faculty of Medicine
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy